Loading clinical trials...
Loading clinical trials...
It is recommended as the first line treatment regimen to eradicate Helicobacter pylori (HP), 7 or 14 days treatment of proton pump inhibitor (PPI) based triple therapy consisting of one PPI and two an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
St.Paul's Hospital, Korea
NCT06579365 · H.Pylori Gastrointestinal Disease, H Pylori Infection
NCT03592069 · H.Pylori Infection, H.Pylori Gastrointestinal Disease, and more
The Catholic University of Korea
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions